Search research articles
Contact Us
Filters
Showing results (31-40 of 40) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 40 results.
Lancet (London, England)
|
December 3, 1977
Increased brain dopamine and reduced glutamic acid decarboxylase and choline acetyl transferase activity in schizophrenia and related psychoses
E D Bird, E G Spokes, J Barnes, et al.
Life Sciences
|
August 7, 1978
3H-Spiperone binding in normal and schizophrenic post-mortem human brain
A V Mackay, A Doble, E D Bird, et al.
Advances in Biochemical Psychopharmacology
|
January 1, 1980
Dopaminergic abnormalities in postmortem schizophrenic brain
A V Mackay, E D Bird, L L Iversen, et al.
Lancet (London, England)
|
October 25, 1980
Dopamine receptors and schizophrenia: drug effect or illness?
A V Mackay, E D Bird, E G Spokes, et al.
Neurology
|
April 13, 2000
A 10-year study of the incidence of and factors predicting dementia in Parkinson's disease
T A Hughes, H F Ross, S Musa, et al.
Advances in Neurology
|
January 1, 1996
The evolution and profile of dementia in Parkinson's disease
H F Ross, T A Hughes, J L Boyd, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
July 1, 1992
A controlled, longitudinal study of dementia in Parkinson's disease
C A Biggins, J L Boyd, F M Harrop, et al.
Advances in Neurology
|
January 1, 1993
A controlled study of dementia in Parkinson's disease over 54 months
R H Mindham, C A Biggins, J L Boyd, et al.
The Journal of Physiology
|
August 1, 1979
Dopamine and homovanillic acid concentrations in the post-mortem brain in schizophrenia [proceedings]
E D Bird, T J Crow, L L Iversen, et al.
Psychological Medicine
|
November 1, 1991
Cognitive impairment and dementia in Parkinson's disease: a controlled study
J L Boyd, C A Cruickshank, C W Kenn, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 40) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 40 results.
Lancet (London, England)
|
December 3, 1977
Increased brain dopamine and reduced glutamic acid decarboxylase and choline acetyl transferase activity in schizophrenia and related psychoses
E D Bird, E G Spokes, J Barnes, et al.
Life Sciences
|
August 7, 1978
3H-Spiperone binding in normal and schizophrenic post-mortem human brain
A V Mackay, A Doble, E D Bird, et al.
Advances in Biochemical Psychopharmacology
|
January 1, 1980
Dopaminergic abnormalities in postmortem schizophrenic brain
A V Mackay, E D Bird, L L Iversen, et al.
Lancet (London, England)
|
October 25, 1980
Dopamine receptors and schizophrenia: drug effect or illness?
A V Mackay, E D Bird, E G Spokes, et al.
Neurology
|
April 13, 2000
A 10-year study of the incidence of and factors predicting dementia in Parkinson's disease
T A Hughes, H F Ross, S Musa, et al.
Advances in Neurology
|
January 1, 1996
The evolution and profile of dementia in Parkinson's disease
H F Ross, T A Hughes, J L Boyd, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
July 1, 1992
A controlled, longitudinal study of dementia in Parkinson's disease
C A Biggins, J L Boyd, F M Harrop, et al.
Advances in Neurology
|
January 1, 1993
A controlled study of dementia in Parkinson's disease over 54 months
R H Mindham, C A Biggins, J L Boyd, et al.
The Journal of Physiology
|
August 1, 1979
Dopamine and homovanillic acid concentrations in the post-mortem brain in schizophrenia [proceedings]
E D Bird, T J Crow, L L Iversen, et al.
Psychological Medicine
|
November 1, 1991
Cognitive impairment and dementia in Parkinson's disease: a controlled study
J L Boyd, C A Cruickshank, C W Kenn, et al.
Page
of 4